Cargando…
New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides
Influenza A viral (IAV) fusion peptides are known for their important role in viral-cell fusion process and membrane destabilization potential which are compatible with those of antimicrobial peptides. Thus, by replacing the negatively or neutrally charged residues of FPs with positively charged lys...
Autores principales: | Wu, Wenjiao, Lin, Dongguo, Shen, Xintian, Li, Fangfang, Fang, Yuxin, Li, Kaiqun, Xun, Tianrong, Yang, Guang, Yang, Jie, Liu, Shuwen, He, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575187/ https://www.ncbi.nlm.nih.gov/pubmed/26382764 http://dx.doi.org/10.1371/journal.pone.0138426 |
Ejemplares similares
-
A “building block” approach to the new influenza A virus entry inhibitors with reduced cellular toxicities
por: Lin, Dongguo, et al.
Publicado: (2016) -
Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin
por: Yang, Jie, et al.
Publicado: (2013) -
Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry
por: Wu, Wenjiao, et al.
Publicado: (2015) -
Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
por: Jiang, Shibo, et al.
Publicado: (2010) -
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
por: Schmidt, Aaron G., et al.
Publicado: (2010)